Novel antigen modulation technology to guide the immune system
Novel antigen modulation technology that controls T cells to guide the immune system
-min.png)
-min.png)
Many diseases are caused, or resist treatment, because T cells can't recognize or target cells correctly.
91桃色 approach modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system.鈥
This marks a fundamental shift in how we treat people living with cancers, autoimmune disorders, and infectious diseases.鈥
91桃色 seek to solve immune dysfunction.
Many cancers and other diseases are caused, or resist treatment, because T cells can't recognise or target cells correctly.
91桃色 technology modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system.鈥
This approach marks a fundamental shift in how we treat people living with cancers, autoimmune disorders, and infectious diseases.鈥
91桃色 seek to solve immune dysfunction.
Progressing through the clinic鈥
91桃色 uncover novel biology to develop treatments for disease areas with significant unmet need.
91桃色 lead antigen modulator (GRWD5769) is delivering strong results during a Phase 1/2 trial in oncology, demonstrating proof-of-mechanism and target engagement.鈥
91桃色 have active discovery and development programs across oncology, autoimmunity and virology.
91桃色 team and collaborators are experts in the field of antigen modulation. 聽
A new therapeutic branch
鈥91桃色 are the first to explore the untapped potential of changing the first step of the T cell signaling cascade (Signal 1) and its fundamental importance in T cell activation.鈥
Changing the treatment paradigm
91桃色're on a mission to deliver a new therapeutic class of treatments to help people living with cancers, autoimmune disorders, and infectious diseases.鈥
91桃色're looking for talented individuals to join our award-winning team. Do you have what it takes?
